Literature DB >> 12392404

A perturbed pK(a) at the binding site of the nicotinic acetylcholine receptor: implications for nicotine binding.

E James Petersson1, Anita Choi, David S Dahan, Henry A Lester, Dennis A Dougherty.   

Abstract

A series of tethered quaternary ammonium derivatives of Tyr have been incorporated into the binding site of the nicotinic acetylcholine receptor (nAChR) using the in vivo nonsense suppression method, producing constitutively active (self-gating) receptors. We have incorporated primary, secondary, and tertiary amine tethered agonists to give receptors whose constitutive activity can be modulated by pH. Lowering the pH protonates the tethered amine, giving it a positive charge and allowing it to reversibly activate the receptor. Tertiary and secondary tethered amines, TyrO3T and TyrO3S, have been successfully incorporated at alpha149 in the nAChR. Constitutive currents at pH 5.5 are 6 times those at pH 9.0. The pKa of TyrO3T in the binding site appears to be 6 or lower, differing substantially from its pKa in solution ( approximately 9.3). This local pKa perturbation has substantial implications for pharmacological research on the nAChR: of the tertiary agonists considered, noracetylcholine experiences this pKa perturbation, while nicotine does not.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12392404     DOI: 10.1021/ja028206i

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  5 in total

1.  Modeling multiple species of nicotine and deschloroepibatidine interacting with alpha4beta2 nicotinic acetylcholine receptor: from microscopic binding to phenomenological binding affinity.

Authors:  Xiaoqin Huang; Fang Zheng; Peter A Crooks; Linda P Dwoskin; Chang-Guo Zhan
Journal:  J Am Chem Soc       Date:  2005-10-19       Impact factor: 15.419

Review 2.  In vivo incorporation of non-canonical amino acids by using the chemical aminoacylation strategy: a broadly applicable mechanistic tool.

Authors:  Dennis A Dougherty; Ethan B Van Arnam
Journal:  Chembiochem       Date:  2014-07-02       Impact factor: 3.164

3.  Photoactivatable drugs for nicotinic optopharmacology.

Authors:  Sambashiva Banala; Matthew C Arvin; Nicholas M Bannon; Xiao-Tao Jin; John J Macklin; Yong Wang; Can Peng; Guiqing Zhao; John J Marshall; Kyle R Gee; David L Wokosin; Veronica J Kim; J Michael McIntosh; Anis Contractor; Henry A Lester; Yevgenia Kozorovitskiy; Ryan M Drenan; Luke D Lavis
Journal:  Nat Methods       Date:  2018-03-26       Impact factor: 28.547

4.  Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensors.

Authors:  Amol V Shivange; Philip M Borden; Anand K Muthusamy; Aaron L Nichols; Kallol Bera; Huan Bao; Ishak Bishara; Janice Jeon; Matthew J Mulcahy; Bruce Cohen; Saidhbhe L O'Riordan; Charlene Kim; Dennis A Dougherty; Edwin R Chapman; Jonathan S Marvin; Loren L Looger; Henry A Lester
Journal:  J Gen Physiol       Date:  2019-02-04       Impact factor: 4.086

5.  Charge Regulation during Amyloid Formation of α-Synuclein.

Authors:  Tinna Pálmadóttir; Anders Malmendal; Thom Leiding; Mikael Lund; Sara Linse
Journal:  J Am Chem Soc       Date:  2021-05-17       Impact factor: 15.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.